| |
|
|
|
Capricor Therapeutics Inc.  
|
|
1.12 0.05 (0.07%) |
09-25 16:00 |
|
Open: |
1.07 |
Pre close: |
1.05 |
Target:
|
1.36 
|
|
High: |
1.14 |
Low: |
1.07 |
Resistance:
|
1.16
1.23
|
|
Volume: |
155,149 |
Market Cap: |
34M |
Support:
|
1.05
0.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.10
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.15 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
1.26 |
Stochastic Oscillator |
%K(14,3):
|
17.61 |
|
MA(250): |
1.63 |
%D(3): |
15.03 |
|
Average Volume(K) |
3-Month: |
18916
|
52-Week |
High:
|
4.25 |
|
10-Days: |
10445 |
Low: |
0.97 |
|
RSI |
RSI(14):
|
46.29 |
Change(%): |
-48.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.510 |
Return on Equity (ttm) |
122.6 |
Shares Out. (M) |
30.75 |
|
EPS Est. Current Year |
-0.700 |
Return on Assets (ttm) |
12.3 |
Shares Float (M) |
27.07 |
|
EPS Est. Next Year |
-0.760 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
-59.5 |
% Held by Institutions |
3.50 |
|
Forward EPS |
-0.430 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1230 |
|
Book Value (p.s.) |
3.580 |
EBITDA (p.s.) |
-0.084 |
P/E |
-2.20 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.31 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.97 |
P/S |
574000064.00 |
|
Operating Margin |
-864.19 |
Levered Free Cash Flow
(M) |
-8.03 |
P/CF |
-2.66 |
|
|
|
|
|
|
